Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Matteelli

Showing results (21-30 of 203) with videos related to

Pageof 21
Sort By:
Current Opinion in Infectious Diseases|January 24, 2022
Mycobacterial skin infectionGiulia Gardini, Natalia Gregori, Alberto Matteelli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 8, 2023
Programmatic management of tuberculosis preventive therapy: Past, present, futureAlberto Matteelli, Sofia Lovatti, Anita Sforza, et al.
The New England Journal of Medicine|May 29, 2015
Latent Mycobacterium tuberculosis infectionHaileyesus Getahun, Alberto Matteelli, Richard E Chaisson, et al.
Clinical Pharmacokinetics|April 30, 2014
Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycinsMario Regazzi, Anna Cristina Carvalho, Paola Villani, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 20, 2014
Tuberculosis: epidemiology and controlGiorgia Sulis, Alberto Roggi, Alberto Matteelli, et al.
Respiratory Medicine|October 29, 2021
Pulmonary nontuberculous mycobacterial infections and environmental factors: A review of the literatureGiulia Gardini, Margherita Ori, Luigi Ruffo Codecasa, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|April 9, 2009
Diagnosis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: Current standards and challengesGiovanni Battista Migliori, Alberto Matteelli, Daniela Cirillo, et al.
AIDS (London, England)|January 6, 2016
Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIVSaskia Den Boon, Alberto Matteelli, Nathan Ford, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 8, 2022
The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infectionDelia Goletti, Giovanni Delogu, Alberto Matteelli, et al.
Future Microbiology|June 5, 2010
TMC207: the first compound of a new class of potent anti-tuberculosis drugsAlberto Matteelli, Anna Cc Carvalho, Kelly E Dooley, et al.
Pageof 21

Showing results (21-30 of 203) with videos related to

Sort By:
Pageof 21
Current Opinion in Infectious Diseases|January 24, 2022
Mycobacterial skin infectionGiulia Gardini, Natalia Gregori, Alberto Matteelli, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 8, 2023
Programmatic management of tuberculosis preventive therapy: Past, present, futureAlberto Matteelli, Sofia Lovatti, Anita Sforza, et al.
The New England Journal of Medicine|May 29, 2015
Latent Mycobacterium tuberculosis infectionHaileyesus Getahun, Alberto Matteelli, Richard E Chaisson, et al.
Clinical Pharmacokinetics|April 30, 2014
Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycinsMario Regazzi, Anna Cristina Carvalho, Paola Villani, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 20, 2014
Tuberculosis: epidemiology and controlGiorgia Sulis, Alberto Roggi, Alberto Matteelli, et al.
Respiratory Medicine|October 29, 2021
Pulmonary nontuberculous mycobacterial infections and environmental factors: A review of the literatureGiulia Gardini, Margherita Ori, Luigi Ruffo Codecasa, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|April 9, 2009
Diagnosis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: Current standards and challengesGiovanni Battista Migliori, Alberto Matteelli, Daniela Cirillo, et al.
AIDS (London, England)|January 6, 2016
Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIVSaskia Den Boon, Alberto Matteelli, Nathan Ford, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 8, 2022
The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infectionDelia Goletti, Giovanni Delogu, Alberto Matteelli, et al.
Future Microbiology|June 5, 2010
TMC207: the first compound of a new class of potent anti-tuberculosis drugsAlberto Matteelli, Anna Cc Carvalho, Kelly E Dooley, et al.
Pageof 21